Navigation Links
NeoStem Vice President Will Speak on VSELs and Emerging Stem Cell Technologies at Age Management Medicine Conference
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that Alan Harris, M.D., Ph.D., the Company's Vice President of Drug Development and Regulatory Affairs, will speak at a conference on Clinical Applications for Age Management Medicine, taking place in Las Vegas, November 5-8, 2009.

Dr. Harris's presentation will take place during a special pre-conference session on November 5, 2009, focused on "Regenerative Medicine: From Autologous Platelet Derived Growth Factors (PRP) to Stem Cells." The subject of his talk is "The Apheresis Product: A Rich Source of Pluripotent VSELs, Stem Cells and Progenitor Cells for Autologous Banking and Cellular Therapies."

Apheresis utilizes a minimally invasive procedure that members of NeoStem's collection network employ to collect stem cells from peripheral blood to store, using NeoStem's proprietary cryogenic technology, for the donor's personal use in time of medical need. NeoStem also holds a worldwide exclusive license to VSEL (Very Small Embryonic-Like) Cell Technology, and is supporting research programs at the University of Louisville as well as engaging in its own research and development activities. As Vice President of Drug Development and Regulatory Affairs, Dr. Harris oversees the Company's progress in these cutting edge arenas.

The Las Vegas events are organized by the Age Management Medicine Group (AMMG), dedicated to educating physicians and healthcare professionals on this growing medical specialty, age management medicine, through evidence-based scientific medical education conferences, workshops, seminars, publications and Web media. The Group, now in its fifth year, consists of leading industry healthcare professionals, physicians, practitioners, researchers, medical associations and providers of products and services. Attending the conference will be physicians, researchers, and health professionals, including dentists, chiropractors, nurses, physician assistants, nurse practitioners, pharmacists, psychologists and medical students.

Age management medicine is a proactive, preventive approach focused on preservation of optimum human function and quality of life, making every effort to modulate the process of aging prior to the onset of degenerative aging. The basic tenets of age management medicine are patient evaluation through extensive medical history, lifestyle assessment, physical examination and laboratory evaluation to establish personalized proactive treatment plans consisting of proper diet, exercise, stress management and appropriate medical interventions.

About NeoStem, Inc.

NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times of future medical need. The Company has also entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells and is pursuing other technologies to advance its position in the field of stem cell tissue regeneration. In 2009, the Company began to expand its operations into China in connection with the development of therapeutic adult stem cell technologies and is seeking to generate revenues through its regenerative medicine programs and technologies in China. For more information, please visit: www.neostem.com.

www.neostem.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and the Company's other periodic filings with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

    CONTACT:
    NeoStem, Inc.
    Robin Smith, Chief Executive Officer
    T: 212-584-4180
    E: rsmith@neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoStem to Present at Rodman & Renshaws 11th Annual Healthcare Conference
2. NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs
3. NeoStem Signs Agreement for Ceres Living, Inc. to Market Innovative Nutritional Supplement Designed to Optimize Stem Cell Functions
4. NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey
5. Suzanne Somers Appears on CNBCs Conversations with Michael Eisner and Discusses NeoStems Adult Stem Cell Collection Program
6. NeoStem Signs Definitive Agreement to Acquire Controlling Interest in a Leading Chinese Pharmaceutical Company
7. NeoStem, Inc. Comments on Recent Selling Pressure
8. NeoStem Signs Stem Cell Collection Agreement With University of Louisville Hospital
9. New Report to President and Congress Addresses Serious Oversights in National Health Care Debate
10. New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Groups American subsidiary, Helsinn Therapeutics (U.S.) Inc.
11. Pelosi, Reid Remarks at Press Availability Following Meeting With President Obama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found ... The 550 employees of Sun Health Senior Living (SHSL) may not share ... their doctor and prescription copays for the year, while holding the line on increasing ...
(Date:5/26/2016)... ... , ... The Lung Institute has partnered with the Gulfcoast North ... 6 at their clinic in downtown Tampa. The class is complimentary for the public. ... created a free downloadable 4 Week Smoking Cessation Guide for those who ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eugene Batelli, ... Along with his wonderful accolades and stellar patient reviews, Dr. Batelli continues to ... , Dr. Eugene Batelli is a highly trained Podiatric Surgeon who specializes in ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 2016 ReportsnReports.com adds "Chronic ... that provides an overview on therapeutic pipeline of ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Chronic Cough ...
(Date:5/24/2016)... May 24, 2016 Cirujanos holandeses ... ayudar a los médicos a compartir sus mejores prácticas ... escala mundial. Profesionales médicos de Europa, África, ... apuntado a la aplicación, que combina la transmisión en ... totalmente seguro. Educación   "Imagine un ...
(Date:5/24/2016)...   , Study met ... and superiority in , Excellent plus ... of the ascending colon   , ... B.V. today announced new positive data from the phase III MORA ... standard 2 litre PEG with ascorbate. The study met both primary ...
Breaking Medicine Technology: